IMUX (STOCKS)
Immunic, Inc. Common Stock
$1.210300
+0.040300 (+3.44%)
Prev close: $1.170000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Daniel Vitt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $160.47M
- Employees
- 90
- P/E (TTM)
- -1.63
- P/B (TTM)
- -22.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.07 | $-0.10 | +0.0260 | +27.08% |
|
Sep 2025 (Q3)
|
$-0.13 | $-0.17 | +0.0409 | +23.93% |
|
Jun 2025 (Q2)
|
$-0.20 | $-0.17 | -0.0317 | -18.84% |
|
Mar 2025 (Q1)
|
$-0.25 | $-0.24 | -0.0086 | -3.56% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $6.06M |
| Operating Expenses | $103.23M |
| Depreciation and Amortization | $168.00K |
| Research and Development | $81.98M |
| Other Operating Expenses | $21.08M |
| Operating Income/Loss | -$103.23M |
| Income/Loss From Continuing Operations After Tax | -$97.17M |
| Income/Loss From Continuing Operations Before Tax | -$97.17M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$97.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$97.17M |
| Net Income/Loss Available To Common Stockholders, Basic | -$97.17M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $497.00K |
| Basic Earnings Per Share | -$0.62 |
| Diluted Earnings Per Share | -$0.62 |
| Basic Average Shares | 155,688,030 |
| Diluted Average Shares | 155,688,030 |
| Common Stock Dividends | $0.00 |
| Assets | $24.05M |
| Current Assets | $22.87M |
| Noncurrent Assets | $1.18M |
| Fixed Assets | $608.00K |
| Other Non-current Assets | $575.00K |
| Liabilities | $30.73M |
| Current Liabilities | $30.62M |
| Accounts Payable | $10.14M |
| Other Current Liabilities | $20.48M |
| Noncurrent Liabilities | $107.00K |
| Equity | -$6.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$6.67M |
| Liabilities And Equity | $24.05M |
| Net Cash Flow From Operating Activities | -$85.81M |
| Net Cash Flow From Operating Activities, Continuing | -$85.81M |
| Net Cash Flow From Investing Activities | -$161.00K |
| Net Cash Flow From Investing Activities, Continuing | -$161.00K |
| Net Cash Flow From Financing Activities | $65.58M |
| Net Cash Flow From Financing Activities, Continuing | $65.58M |
| Exchange Gains/Losses | $205.00K |
| Net Cash Flow | -$20.19M |
| Net Cash Flow, Continuing | -$20.39M |
| Comprehensive Income/Loss | -$98.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$98.73M |
| Other Comprehensive Income/Loss | -$98.73M |